Bellei, Ericles Andrei http://orcid.org/0000-0002-6020-6356
de Carvalho, André Vicente Esteves
Eng, Beatriz Magalhães
Tozato, Carla
de Barros, Danilo Hamilko
Tamashiro, Erika Yumi
Duarte, Gleison Vieira
de Fátima, Rafael Toledo Rodrigues
Magalhães, Renata Ferreira
da Silva, Roberto Souto
Cesar, Wagner Guimarães Galvão
Thies, Felipe Garutti
Funding for this research was provided by:
Novartis
Article History
Received: 21 August 2023
Accepted: 6 September 2023
First Online: 4 October 2023
Declarations
:
: André Vicente Esteves de Carvalho, Danilo Hamilko de Barros, Gleison Vieira Duarte, Roberto Souto da Silva, Renata Ferreira Magalhães, and Wagner Guimarães Galvão Cesar have received grants, consulting fees, or speaking honoraria from companies, including but not limited to AbbVie, Amgen, Bayer, Biolab, Boehringer Ingelheim, Eli-Lilly, Galderma, Janssen, Leo Pharma, Novartis, Pfizer, Sandoz, Sanofi, or UCB. Ericles Andrei Bellei, Beatriz Magalhães Eng, Carla Tozato, Erika Yumi Tamashiro, Rafael Toledo Rodrigues de Fátima, and Felipe Garutti Thies are employed by Novartis.
: All the data collected, analyzed, and presented in this study were exclusively sourced from public and openly accessible platforms. All the narratives collected were anonymized prior to any analysis. This article underwent review by the scientific committee of Novartis (code CLR-12165/AIN-MS-117664) and was approved for publication without requiring any additional review by an ethics committee.